SpringWorks Therapeutics Inc (SWTX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
SpringWorks Therapeutics, Inc. - common stock (SWTX)
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
SpringWorks Therapeutics Inc ( NASDAQ:SWTX ) reported $49.3 million in net product revenue for the third quarter, representing a 23% growth quarter over quarter. The company has successfully launched 100 mg and 150 mg strength tablets in blister packaging, improving patient convenience and adherence. The addressable patient population for desmoid tumors is larger than initially estimated, with 10,000 unique patients identified through new diagnosis codes. SpringWorks Therapeutics Inc ( NASDAQ:SWTX ) has a strong balance sheet with $498 million in cash, cash equivalents, and marketable securities, expected to fund operations through profitability by the first half of 2026. The NDA for nirogacestat for NF1-PN has been granted priority review, with potential FDA approval anticipated in early 2025, positioning it as a first-in-class treatment for adults and a best-in-class option for children. The transition to blister packs caused short-term delays in prescription refills, imp
Show less
Read more
Impact Snapshot
Event Time:
SWTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SWTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SWTX alerts
High impacting SpringWorks Therapeutics, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
SWTX
News
- Wedbush ups SpringWorks target to $81, expects Merck KGaA ‘official' offer soon [Yahoo! Finance]Yahoo! Finance
- Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics [Yahoo! Finance]Yahoo! Finance
- InnovationRx: Federal Judges Halt Trump’s Cuts To NIH Research Payments [Forbes]Forbes
- SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its price target raised by analysts at Evercore ISI from $60.00 to $65.00. They now have an "outperform" rating on the stock.MarketBeat
- SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.MarketBeat
SWTX
Earnings
- 11/12/24 - Beat
SWTX
Sec Filings
- 2/14/25 - Form 4
- 2/14/25 - Form 144
- 2/14/25 - Form SCHEDULE
- SWTX's page on the SEC website